Filing Details
- Accession Number:
- 0001477932-25-002516
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-08 12:11:23
- Reporting Period:
- 2025-03-18
- Filing Date:
- 2025-04-08
- Accepted Time:
- 2025-04-08 12:11:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924515 | Guided Therapeutics Inc | GTHP | Electromedical & Electrotherapeutic Apparatus (3845) | 582029543 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365831 | C Michael James | 5835 Peachtree Corners East Suite B Peachtree Corners GA 30092 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-18 | 150,000 | $0.10 | 262,772 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-03-18 | 262,945 | $0.10 | 525,717 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Acquisiton | 2025-03-18 | 150,000 | $0.00 | 150,000 | $0.13 |
| Common Stock | Warrants | Acquisiton | 2025-03-18 | 262,945 | $0.00 | 262,945 | $0.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 150,000 | 2025-03-18 | 2029-03-17 | No | 4 | P | Direct |
| 412,945 | 2025-03-18 | 2029-03-17 | No | 4 | P | Direct |
Footnotes
- On March 18, 2025, the Company entered into a Securities Purchase Agreement (the "March Purchase Agreement") with Mr. James, pursuant to which the Company agreed to sell, for a total price of $15,000, an aggregate of 150,000 units, each unit consisting of one share of common stock and one warrant to purchase up to 150,000 shares of common stock (the "March Warrants"). The March Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.13 per share.
- In connection with the March Purchase Agreement, the Company entered into an exchange agreement with Mr. James, whereby Mr. James agreed to exchange a $25,000 note payable and accrued interest of $1,295 for 262,945 units as described above.
Billionaire Hedge Funds
